ホームポートフォリオウォッチリストコミュニティ発見スクリーナー
NOT FOR DISTRIBUTION

IMAX Corporation

NYSE:IMAX 株式レポート

時価総額:US$2.9b

  • 会社概要
    • 評価
    • 将来の成長
    • 過去の実績
    • 財務の健全性
    • 配当金
  • マネジメント
  • 所有権
  • その他の情報
  • 株式コミュニティ

IMAX 将来の成長

Future 基準チェック /36

IMAX利益と収益がそれぞれ年間21.6%と6.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に16.9% 27.5%なると予測されています。

主要情報

21.6%

収益成長率

27.51%

EPS成長率

Entertainment 収益成長24.0%
収益成長率6.3%
将来の株主資本利益率16.86%
アナリストカバレッジ

Good

最終更新日09 Sep 2026

今後の成長に関する最新情報

Recent updates

User avatar
ナラティブ更新 • Sep 07

IMAX: Premium Formats And Network Expansion Will Shape Balanced Odyssey-Led Outlook

IMAX's analyst fair value estimate has shifted from $52.73 to $55.65 as analysts lift price targets into the $60 to $65 range, citing stronger box office contributions from The Odyssey, higher Q3 revenue expectations, and ongoing network growth. Analyst Commentary Recent commentary on IMAX is skewed toward optimism, with many bullish analysts lifting price targets into the $60 to $65 range, while a smaller group urges more caution.
User avatar
ナラティブ更新 • Aug 24

IMAX: Premium Formats And Network Expansion Will Underpin Balanced Future Outlook

Analysts have nudged their fair value estimate for IMAX higher, with the updated target of $52.73 from $50.27. This reflects recent price target increases tied to stronger Q3 box office expectations around "The Odyssey," ongoing momentum in premium formats, and anticipated margin and cash flow benefits from network expansion.
User avatar
ナラティブ更新 • Aug 07

IMAX: Premium Formats And Sale Optionality Will Shape Balanced Future Outlook

Analysts have raised the IMAX fair value estimate from about $46.82 to roughly $50.27, citing higher Street price targets clustered around $50 to $54. They highlight stronger Q2 results, growing consumer preference for IMAX screenings, and continued network expansion supported by titles like The Odyssey.
User avatar
ナラティブ更新 • Jul 24

IMAX: Filmed For Large Format Slate And Potential Sale Will Support Upside

Analysts have raised the updated fair value estimate for IMAX from $55.99 to $59.72, citing higher Street price targets supported by a Q2 earnings beat, strong performance from "The Odyssey," increasing demand for filmed-for-IMAX content, and ongoing global system installations. Analyst Commentary Bullish analysts covering IMAX are largely framing the recent Q2 earnings beat and the success of "The Odyssey" as key supports for higher valuation ranges, with a series of price target increases reflecting confidence in both execution and growth initiatives.
Seeking Alpha • Jul 24

IMAX Corporation: Box Office Expansion Drives The Investment

Summary IMAX Corporation reported solid Q2 results, driven by higher system installations in theaters. The short-term forward outlook is driven by a favorable film slate, notably including The Odyssey, filmed fully on IMAX 70mm film cameras. IMAX should continue to gain box office market share in upcoming years, driven by filmmaker interest and theater network expansion. After a strong stock rally, IMAX stock's base scenario growth potential is already priced in. I estimate a fair value of $43.9. Read the full article on Seeking Alpha
分析記事 • Jun 18

IMAX (IMAX) Stock Could Be 5.3% Undervalued After Disclosure Day Opening Weekend

IMAX (IMAX) stock moved after Universal’s Disclosure Day delivered a robust opening weekend, with IMAX premium screens capturing nearly 15% of the film’s US$93.9 million global box office. See our latest analysis for IMAX. Beyond this weekend’s box office boost, IMAX’s recent share price momentum has been building, with a 30 day share price return of 33.97% and a 1 year total shareholder return of 51.82% reflecting how investors are reassessing both growth potential and risk. If this kind of...
User avatar
ナラティブ更新 • Jun 15

IMAX: Film Slate Management And Potential Sale Will Support Future Upside

The analyst price target for IMAX has increased from $47.00 to about $56.00, as analysts point to stronger margin potential, active film slate management and renewed interest following reports that the company is exploring a possible sale. Analyst Commentary Recent research has centered on how the current film slate, margin potential and potential corporate activity could affect the stock's valuation.
User avatar
ナラティブ更新 • Jun 01

IMAX: Premium Formats And Potential Sale Interest Will Drive Future Upside

Analysts have nudged their implied fair value estimate for IMAX higher from about $45.27 to $46.82, citing expectations for stronger revenue growth, higher forecast margins, and recent Street research that highlights potential corporate interest in the company. Analyst Commentary Recent Street research around IMAX reflects an active debate on valuation, execution, and potential corporate interest in the company.
User avatar
ナラティブ更新 • May 02

IMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power

The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.
User avatar
ナラティブ更新 • Apr 18

IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside

The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.
User avatar
ナラティブ更新 • Apr 04

IMAX: Future Earnings Base And Global Footprint Frame Balanced Opportunity And Risk

Narrative Update: IMAX Analyst Price Target Shift The analyst price target for IMAX has moved to $41.00. Analysts cite record share gains, accelerating international expansion, strong Q4 and full-year revenue and margins, and continued outperformance versus consensus as key factors influencing their updated views.
User avatar
ナラティブ更新 • Mar 21

IMAX: Record Box Office And Premium Format Position Will Support Future Upside

The analyst price target for IMAX is raised by about $1 to $45.00, as analysts factor in higher margin expectations, a lower assumed future P/E multiple, and recent research citing strong quarterly results, record box office driven revenue, and a stronger position in the global theatrical ecosystem. Analyst Commentary Recent research updates show a cluster of target price increases for IMAX, with analysts reacting to reported results, box office trends, and the company’s role in premium theatrical formats.
User avatar
ナラティブ更新 • Mar 06

IMAX: Future Earnings Base And International Footprint Suggest Balanced Opportunity And Risk

The Analyst Price Target for IMAX has increased from $22.04 to $41.00. This reflects analysts' views that recent record revenue, strong margins, higher box office activity and an expanding international footprint support a higher assumed profit margin and P/E multiple in updated models.
User avatar
ナラティブ更新 • Feb 20

IMAX: Live Sports And Content Partnerships Will Support Future Upside

Analysts have maintained their $47.00 price target on IMAX, citing updated assumptions around discount rate, revenue growth, profit margin, and a higher future P/E multiple. They also highlight broader sector risks such as high development costs, dependence on single assets, and limited near term catalysts in comparable coverage.
User avatar
ナラティブ更新 • Feb 05

IMAX: Future Slate And Execution Will Support Expanded Premium Format Opportunities

Analysts have inched their price target for IMAX higher to approximately US$44.09 from about US$43.73, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. Analyst Commentary Analysts have updated their IMAX models around revenue, margins and future P/E levels, which feeds directly into the small lift in the price target to about US$44.09.
User avatar
ナラティブ更新 • Jan 22

IMAX: Future Slate And Profit Execution Will Support Measured Upside Potential

Analysts have lifted their IMAX fair value estimate from about US$38.81 to roughly US$43.73 per share, citing updated assumptions for revenue growth, profit margins and a lower future P/E that together support a higher price target. Analyst Commentary Analysts reviewing IMAX after the updated fair value estimate are split between what could support the higher valuation and what might limit upside if execution falls short.
User avatar
ナラティブ更新 • Jan 08

IMAX: Premium Screens And Local Language Hits Will Support Future Upside

Analysts have raised their price target on IMAX to $40 from $36, citing record Q3 global box office results, an increasing market share, strong local language titles, and faster-than-expected network expansion in markets with above-average revenue per screen. Analyst Commentary Bullish analysts point to IMAX's recent record Q3 global box office results and its second highest quarterly gross as key supports for their updated views, highlighting what they see as solid execution across the business.
User avatar
ナラティブ更新 • Dec 21

IMAX: Expanding Premium Network Will Drive Stronger Box Office Performance

Analysts have lifted their price target on IMAX to approximately $47 from about $38, citing accelerating network expansion into higher revenue markets, record and resilient box office performance, and an expectation for stronger, more profitable growth that, in their view, supports a lower forward earnings multiple versus historical levels. Analyst Commentary Bullish analysts have recently highlighted IMAX as one of the stronger execution stories in the theatrical ecosystem, pointing to a mix of box office outperformance, premium market exposure, and disciplined capital deployment as key supports for higher valuation.
User avatar
ナラティブ更新 • Dec 07

IMAX: Future Slate And Premium Screen Expansion Will Drive Measured Performance

We raise our IMAX price target to approximately $39 from about $37, as analysts highlight record Q3 box office performance, accelerating high value screen expansion, and a robust Q4 film slate that together support modestly stronger growth and valuation assumptions. Analyst Commentary Recent Street commentary on IMAX has tilted clearly positive, with multiple firms raising price targets in response to stronger than expected operating trends and an improving growth outlook.
User avatar
ナラティブ更新 • Nov 22

IMAX: Future Box Office Releases And Network Expansion Will Shape Performance

IMAX's analyst price target has increased significantly, rising from $36 to $37 per share to $40 to $42 per share, as analysts cite strong quarterly box office results, ongoing network expansion, and promising upcoming film releases as key drivers of growth. Analyst Commentary Recent updates from street research provide insights into the positive momentum behind IMAX's upgraded price targets, as well as areas of continued scrutiny among analysts.
User avatar
ナラティブ更新 • Nov 01

IMAX: Accelerating Network Expansion Will Drive Global Box Office Performance

The analyst consensus price target for IMAX has increased from approximately $36.45 to $37.18. Analysts highlight strong box office performance and accelerating network expansion as key drivers for the upward revision.
User avatar
ナラティブ更新 • Oct 18

North America And Japan Installations Will Strengthen Premium Entertainment

Analysts have raised their price target for IMAX from approximately $34.36 to $36.45. They cite stronger box office performance, accelerating network expansion, and improved margins as key factors supporting the higher valuation.
User avatar
ナラティブ更新 • Oct 04

North America And Japan Installations Will Strengthen Premium Entertainment

IMAX's analyst price target has been raised from $31 to $38, reflecting higher expected margins and valuation multiples according to analysts. Analyst Commentary Analyst sentiment toward IMAX has recently shifted, leading to an upward revision of the company's price target.
分析記事 • Sep 09

Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%

IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
分析記事 • Aug 04

Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?

IMAX Corporation ( NYSE:IMAX ), is not the largest company out there, but it received a lot of attention from a...
分析記事 • Jun 13

An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued

Key Insights IMAX's estimated fair value is US$42.15 based on 2 Stage Free Cash Flow to Equity Current share price of...
分析記事 • May 17

Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher

IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
分析記事 • May 02

IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear

Shareholders appeared unconcerned with IMAX Corporation's ( NYSE:IMAX ) lackluster earnings report last week. We think...
分析記事 • Apr 19

Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?

While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it saw significant share price...
分析記事 • Apr 04

Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
分析記事 • Mar 15

We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Seeking Alpha • Mar 09

IMAX Corporation: Unlocking Asymmetric Gains In Premium Cinema

Summary IMAX remains the leading choice for premium cinema experiences, generating outsized box office returns despite a small footprint of 1% of total screens. The company’s success in China is encouraging, but future box office results may be dampened due to a lack of new local content. IMAX’s global expansion in local language partnerships could face higher costs and challenges adapting to diverse filmmaking workflows. While financially recovered from the pandemic, IMAX’s growth trajectory appears plateaued, with flat revenue and cash flow projections. Given the overvaluation of IMAX stock, investors should hold and wait for a significant price retracement before considering entry. Read the full article on Seeking Alpha
分析記事 • Jan 08

Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?

While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it led the NYSE gainers with a...
Seeking Alpha • Dec 24

IMAX Corporation: Overseas Growth Opportunities

Summary IMAX Corporation's stock has surged 60% since its June lows, but there has been a notable uptick in insider selling in December. IMAX Corporation has considerable long-term growth opportunities and should benefit from an expected well-received movie slate in 2025. An analysis of IMAX Corporation follows in the paragraphs below. Read the full article on Seeking Alpha
分析記事 • Dec 10

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
分析記事 • Nov 23

IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Key Insights IMAX's estimated fair value is US$45.02 based on 2 Stage Free Cash Flow to Equity IMAX's US$25.19 share...
分析記事 • Nov 07

After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

The IMAX Corporation ( NYSE:IMAX ) share price has done very well over the last month, posting an excellent gain of...
分析記事 • Oct 31

Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Oct 13

If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

業績と収益の成長予測

NYSE:IMAX - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2028501951511828
12/31/20274819613017411
12/31/20264618210914411
6/30/202641641100133N/A
3/31/20264053790124N/A
12/31/20254103585127N/A
9/30/20253784064109N/A
6/30/2025362332977N/A
3/31/2025360254089N/A
12/31/2024352263071N/A
9/30/2024346231963N/A
6/30/2024358211757N/A
3/31/202436726-926N/A
12/31/2023375252659N/A
9/30/2023387254371N/A
6/30/202335242148N/A
3/31/2023328-71142N/A
12/31/2022301-23-1517N/A
9/30/2022311-15-426N/A
6/30/2022299-15-718N/A
3/31/2022276-21-713N/A
12/31/2021255-22-126N/A
9/30/2021202-54-25-12N/A
6/30/2021183-93-29-19N/A
3/31/2021141-109-50-40N/A
12/31/2020137-144-32-23N/A
9/30/2020205-104-28-8N/A
6/30/2020254-48-821N/A
3/31/2020350-11N/A97N/A
12/31/201939647N/A90N/A
9/30/201938030N/A109N/A
6/30/201937626N/A112N/A
3/31/201937023N/A94N/A
12/31/201837423N/A110N/A
9/30/201839126N/A90N/A
6/30/201840820N/A95N/A
3/31/201839711N/A101N/A
12/31/20173812N/A85N/A
9/30/20173626N/A96N/A
6/30/201734910N/A79N/A
3/31/201735318N/A72N/A
12/31/201637629N/A78N/A
9/30/201638942N/A87N/A
6/30/201638848N/A102N/A
3/31/201640466N/A83N/A
12/31/201537455N/A84N/A
9/30/201535753N/A57N/A

アナリストによる今後の成長予測

収入対貯蓄率: IMAXの予測収益成長率 (年間21.6% ) は 貯蓄率 ( 3.7% ) を上回っています。

収益対市場: IMAXの収益 ( 21.6% ) はUS市場 ( 17.4% ) よりも速いペースで成長すると予測されています。

高成長収益: IMAXの収益は今後 3 年間で 大幅に 増加すると予想されています。

収益対市場: IMAXの収益 ( 6.3% ) US市場 ( 13.6% ) よりも低い成長が予測されています。

高い収益成長: IMAXの収益 ( 6.3% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: IMAXの 自己資本利益率 は、3年後には低くなると予測されています ( 16.9 %)。


成長企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/09/21 16:51
終値2026/09/18 00:00
収益2026/06/30
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
  • SECフォーム10-K
  • SECフォーム10-Q
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
  • アナリストリサーチレポート
  • Blue Matrix
市場価格30年
  • 株価
  • 配当、分割、措置
  • ICEマーケットデータ
  • SECフォームS-1
所有権10年
  • トップ株主
  • インサイダー取引
  • SECフォーム4
  • SECフォーム13D
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
  • SECフォーム10-K
  • SECフォームDEF 14A
主な進展10年
  • 会社からのお知らせ
  • SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

IMAX Corporation 11 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。20

アナリスト機関
Marla BackerAscendiant Capital Markets LLC
David McFadgenATB Cormark Historical (Cormark Securities)
Patrick ShollBarrington Research Associates, Inc.

どこでもより良い投資判断を

スキャンしてダウンロード
App Store を開くGoogle Play を開く
Chrome ウェブストア
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
データソースを見る
市場
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
投資のアイデア
  • 割安企業
  • 配当優良企業
  • インサイダー買い
  • 原子力
  • 自律走行車
  • 人工知能
  • 暗号資産とブロックチェーン
  • サイバーセキュリティ
  • さらにアイデア
株価コミュニティ
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
機能とツール
  • ポートフォリオ・トラッカー
  • ストックスクリーナー&アラート
  • 語りと公正な値
  • 配当金計算機
ニュース & 発見
  • 最新の在庫ニュース
  • グローバルマーケットインサイト
  • The Foxhole ブログ
  • 投資のアイデア
  • コミュニティの物語
  • 新着情報
Simply Wall St
  • プランと料金
  • 広告
  • 会社概要
  • お問い合わせ
  • 採用情報
  • ヘルプセンター
  • 株式投資を学ぶ
  • アフィリエイト・プログラム
  • ビジネス
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • ご利用条件
  • プライバシーポリシー
  • AI利用規約
  • 金融サービスガイド